Acute Coronary Syndrome

Discharging patients with suspected acute coronary syndrome (ACS) under a 0- and 1-hour high-sensitivity cardiac troponin T protocol is helpful for clearing waiting rooms, according to work presented at the ESC Congress Sept. 3.

Taking a nap once or twice a week—regardless of how long those naps are—can lower a person’s risk of incident heart disease, researchers report in the latest issue of BMJ Heart.

Despite a decades-long decline in the rate of heart attacks among older people in the U.S., younger men in their twenties and thirties are presenting more often with MI, Men’s Health reports.

New York City firefighters exposed to dust and debris from the World Trade Center attacks on and after Sept. 11, 2001, are far more likely to experience an adverse cardiovascular event in the long-term, according to a study published in JAMA Network Open Sept. 6.

A study out of Emory University has revealed a link between education levels and the odds of developing or dying from CVD, with anything under a graduate degree representing a higher risk of heart disease. 

Complete revascularization is superior to culprit-lesion-only PCI in patients with both STEMI and multivessel disease, according to results from the COMPLETE trial, published Sept. 1 in the New England Journal of Medicine.

Heart disease deaths are on the rise in the U.S., according to research published in the Journal of the American Medical Association Aug. 27—and they have been for almost a decade.

Belgium-based Miracor Medical has secured FDA breakthrough device designation for its PiCSO Impulse System, an innovation designed to treat STEMI patients.

Childhood cancer survivors are up to three times more likely than their cancer-free peers to develop various types of heart disease, according to an Aug. 26 study published in Circulation.

Research published in Mayo Clinic Proceedings: Innovations, Quality & Outcomes this month suggests owning a pet—in particular a dog—can be beneficial for cardiovascular health.

A team of researchers in Iran, the U.S. and the U.K. may have cracked the code of the elusive polypill, they reported after finding their four-drug concoction effectively reduced adverse CV events in nearly 3,500 patients.

Women present with “typical” heart attack symptoms more often than men, according to research published August 20 in the Journal of the American Heart Association.